cancer

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

Immunai wants to map the entire immune system and raised $20 million in seed funding to do it

For the past two years the founding team of Immunai had been working stealthily to develop a new technology to map the immune system of any patient. Founded by Noam Solomon, a Harvard and MIT-educated

Lucid Lane has developed a service to get patients off of pain meds and avoid dependence

Four years ago, Adnan Asar, the founder of the new dependence prevention service Lucid Lane, was enjoying a successful career working as the founding chief technology officer at Livongo Health. It was

Owkin raises $25 million as it builds a secure network for healthcare analysis and research

Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data. That’s the

Activ Surgical launches visualization tech for making surgeries safer

After $25 million in funding and three years of development, the Boston-based medical device and software development company Activ Surgical is bringing its first product to market, the company said y

LetsGetChecked raises $71 million as COVID-19 epidemic makes home testing increasingly vital

As the country wrestles with the COVID-19 epidemic, home health testing, checkups and diagnostics have never been more important and companies like LetsGetChecked are filling a void left in a U.S. hea

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic

Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Admin

Paige adds $5M from Goldman Sachs to double down on AI-based cancer therapies

Paige, the Sloan-Kettering spinout that has been building an artificial intelligence platform to improve cancer pathology and subsequently use those insights to develop better drug therapies, has rais

Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19

Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on

Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw

“What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose life sciences startup just hauled

LabCorp security lapse exposed thousands of medical documents

A security flaw in LabCorp’s website exposed thousands of medical documents, like test results containing sensitive health data. It’s the second incident in the past year after LabCorp sai

23andMe co-founder’s new startup, Precise.ly, brings genomics to India through Narayana partnership

Precise.ly, the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with

Xilis believes cultivating micro-tumors may hold the key to more effective cancer treatments

Despite near-miraculous advances in the treatment of cancer in the U.S. and around the world, the disease remains the second leading cause of death in America. The problem is that every manifestation

Paige raises $45M more to map the pathology of cancer using AI

One of the more notable startups using artificial intelligence to understand and fight cancer has raised $45 million more in funding to continue building out its operations and inch closer to commerci

Trialjectory uses self-reported clinical data to match cancer patients with clinical trials

Trialjectory, which is developing a new technology service to match cancer patients with clinical trials, has raised $2.7 million to finance its continued growth. Led by Contour Venture Partners, the

Luna is a new kind of space company helping biotech find its footing in microgravity

Toronto-based startup Luna Design and Innovation is a prime example of the kind of space company that is increasingly starting up to take advantage of the changing economics of the larger industry. Fo

You’ve heard of CRISPR, now meet its newer, savvier cousin CRISPR Prime

CRISPR, the revolutionary ability to snip out and alter genes with scissor-like precision, has exploded in popularity over the last few years and is generally seen as the standalone wizard of modern g

The UK’s National Health Service is launching an AI lab

The UK government has announced it’s rerouting £250M (~$300M) in public funds for the country’s National Health Service (NHS) to set up an artificial intelligence lab that will work to ex

Google’s SMILY is reverse image search for cancer diagnosis

Spotting and diagnosing cancer is a complex and difficult process even for the dedicated medical professionals who do it for a living. A new tool from Google researchers could improve the process by p

Paige details first AI pathology tech with clinical-grade accuracy in new research paper

Researchers associated with Memorial Sloan Kettering Cancer Center and medical tech and computational pathology startup Paige have published a new article in the peer-reviewed medical journal Nature M
Load More